首页> 美国卫生研究院文献>World Journal of Gastroenterology >The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province a non HCC prevalent area in China
【2h】

The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province a non HCC prevalent area in China

机译:中国非HCC流行地区安徽省肝细胞癌中p53基因exon7的点突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: In hepatocellular carcinoma (HCC) prevalent areas of China, the point mutation of p53 exon7 is highly correlated with Hepatitis B virus (HBV) infection and aflatoxin B intake. While in non-HCC-prevalent areas of China, these factors are not so important in the etiology of HCC. Therefore, the point mutation of p53 exon7 may also be different than that in HCC-prevalent areas of China. The aim of this study is to investigate the status and carcinogenic role of the point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non-HCC-prevalent area in China.METHODS: PCR, PCR-SSCP and PCR-RFLP were applied to analyze the homozygous deletion and point mutation of p53 exon7 in HCC samples from Anhui, which were confirmed by DNA sequencing and Genbank comparison.RESULTS: In the 38 samples of hepatocellular carcinoma, no homozygous deletion of p53 exon7 was detected and point mutations of p53 exon7 were found in 4 cases, which were found to be heterozygous mutation of codon 249 with a mutation rate of 10.53% (4/38). The third base mutation (GiúT) of p53 codon 249 was found by DNA sequencing and Genbank comparison.CONCLUSION: The incidence of point mutation of p53 codon 249 is lower in hepatocellular carcinoma and the heterozygous mutation of p53 exon7 found in these patients only indicate that they have genetic susceptibility to HCC. p53 codon 249 is a hotspot of p53 exon7 point mutation, suggesting that the point mutation of p53 exon 7 may not play a major role in the carcinogenesis of HCC in Anhui Province, a non-HCC-prevalent area in China.
机译:目的:在中国肝细胞癌(HCC)流行地区,p53 exon7的点突变与乙型肝炎病毒(HBV)感染和黄曲霉毒素B摄入高度相关。在中国非HCC流行地区,这些因素在HCC的病因学中并不那么重要。因此,p53 exon7的点突变也可能与中国HCC流行地区的点突变不同。本研究的目的是研究p53基因exon7点突变在中国非肝癌流行地区安徽省的肝细胞癌中的地位和致癌作用。方法:PCR,PCR-SSCP和PCR-RFLP结果:在38例肝细胞癌中,未检测到p53 exon7的纯合缺失,且p53 exon7的纯合缺失和点突变均通过DNA测序和Genbank比较得到了证实。在4例中发现p53外显子7,其为249位密码子的杂合突变,突变率为10.53%(4/38)。通过DNA测序和Genbank比较发现p53密码子249的第三个碱基突变(GiúT)。结论:这些p53密码子249点突变在肝细胞癌中的发生率较低,这些患者中p53外显子7的杂合突变仅表明:他们对HCC具有遗传易感性。 p53密码子249是p53外显子7点突变的热点,这表明p53外显子7的点突变可能在中国非HCC流行地区安徽省的HCC致癌过程中不发挥主要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号